Fitzsimons Carlos P, van Hooijdonk Lenneke W A, Morrow John A, Peeters Bernard W M M, Hamilton Niall, Craighead Mark, Vreugdenhil Erno
LACDR/Medical Pharmacology Department, Leiden University, Gorlaeus Laboratory, Einsteinweg 55, 2333CC Leiden, The Netherlands.
Mini Rev Med Chem. 2009 Feb;9(2):249-64. doi: 10.2174/138955709787316001.
Recent evidence suggests that antiglucocorticoids, like conventional antidepressants, may recover depressive symptoms by boosting hippocampal neurogenesis. Here, we explore several possible antiglucocorticoid-based antidepressive therapeutic strategies. Firstly, we review specific glucocorticoid receptor/antagonist interactions. Secondly, we discuss a potential new therapeutic target, doublecortin-like kinase, which regulates glucocorticoid signaling in neuronal progenitor cells.
最近的证据表明,抗糖皮质激素与传统抗抑郁药一样,可能通过促进海马神经发生来缓解抑郁症状。在此,我们探讨几种基于抗糖皮质激素的抗抑郁治疗策略。首先,我们回顾特定的糖皮质激素受体/拮抗剂相互作用。其次,我们讨论一个潜在的新治疗靶点——双皮质素样激酶,它在神经元祖细胞中调节糖皮质激素信号传导。